Choksi Asia

Choksi Imaging Limited was established to manufacture and trade healthcare products, with a primary focus on Medical X-Ray Films for the healthcare industry. Following a proposed amalgamation, the company intends to expand its business to include selling X-Ray films, Lead Screens, Chemicals, and other healthcare and nuclear products. The company's current main business involves processing large rolls of X-ray films by slitting and cutting them into various sizes according to customer requirements. Through this merger, the company aims to strengthen its market position, increase market share, expand its product and service lines, and enter new geographical regions. This consolidation of operations is expected to lead to more efficient use of capital, streamlined administration, and improved organizational efficiencies to boost profitability. Reflecting its recent performance, the company's turnover for the 2023-2024 fiscal year saw a substantial increase to ₹126.7 lakh from ₹76.92 lakh.;